Literature DB >> 8600500

Particle radiotherapy: historical developments and current status.

M R Raju1.   

Abstract

The current status of particle radiotherapy from a historical perspective is presented. This is done with a personal view and contains personal references and memories during the development of particle radiotherapy. The particles covered are fast neutrons, neutron capture therapy, protons, helium ions, pions and heavy ions. International cooperation in the development of the field of particle therapy, its impact on radiobiology and conventional radiotherapy, and some personal reflections and conclusions are also presented briefly.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8600500

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  6 in total

Review 1.  Physical advantages of particles: protons and light ions.

Authors:  Oliver Jäkel
Journal:  Br J Radiol       Date:  2019-09-26       Impact factor: 3.039

2.  Comparison of radiobiological effective depths in 65-MeV modulated proton beams.

Authors:  J T Tang; T Inoue; T Inoue; H Yamazaki; S Fukushima; N Fournier-Bidoz; M Koizumi; S Ozeki; K Hatanaka
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Particle radiation therapy for gastrointestinal malignancies.

Authors:  Jeffrey J Meyer; Brian G Czito; Christopher G Willett
Journal:  Gastrointest Cancer Res       Date:  2007

Review 4.  DNA Damage Clustering after Ionizing Radiation and Consequences in the Processing of Chromatin Breaks.

Authors:  Veronika Mladenova; Emil Mladenov; Martin Stuschke; George Iliakis
Journal:  Molecules       Date:  2022-02-24       Impact factor: 4.411

Review 5.  Dendritic Polymers for Theranostics.

Authors:  Yuan Ma; Quanbing Mou; Dali Wang; Xinyuan Zhu; Deyue Yan
Journal:  Theranostics       Date:  2016-04-27       Impact factor: 11.556

Review 6.  Technological Advances in Charged-Particle Therapy.

Authors:  Jong Min Park; Jung-In Kim; Hong-Gyun Wu
Journal:  Cancer Res Treat       Date:  2021-06-21       Impact factor: 4.679

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.